Key result
Ex vivo liver resection and autotransplantation allowed for the successful treatment of an advanced zone II-III leiomyosarcoma of the inferior vena cava, with the patient surviving 32 months post-surgery despite hepatic recurrence.
Why the study?
Does ex vivo liver resection and autotransplantation improve survival in patients with advanced zone II-III leiomyosarcoma of the IVC?
Case Report (n=1)
No
Does ex vivo liver resection and autotransplantation improve survival in patients with advanced zone II-III leiomyosarcoma of the IVC?
Ex vivo liver resection and autotransplantation is a feasible, albeit aggressive, surgical option for advanced zone II-III leiomyosarcoma of the IVC with hepatic vein involvement.
Supports feasibility of ELRA plus thrombectomy for complex IVC leiomyosarcoma; hypothesis-generating and should not yet change practice.
We report the first documented case of leiomyosarcoma at zone II-III of inferior vena cava with thrombi in three hepatic veins undergoing ex vivo liver resection and autotransplantation (ELRA) and hepatic veins thrombectomy. A 33-year-old female patient presented with abdominal distention and lower extremities edema. Abdominal wall varicosis and shifting dullness were positive on physical examination. Her liver function was classified as Child-Pugh B and a solid tumor at retro-hepatic vena cava extending to right atrium with thrombi in three hepatic veins were confirmed. The diagnosis of leiomyosarcoma with Budd-Chiari syndrome was highly suspected with preoperative ultrasound, echocardiogram, CT scan, and three-dimensional reconstruction. A zone II-III leiomyosarcoma of IVC origin was confirmed at surgery and ex vivo liver resection and autotransplantation, and hepatic vein thrombectomy with atrial reconstruction were performed under cardiopulmonary bypass (CPB). Operative time, anhepatic time, and CPB time were 12 h, 128 min, and 84 min, respectively. The patients experienced post-operative liver dysfunction and was cured with conservative therapy. Hepatic recurrence two years after surgery was managed with radiofrequency. The patient was alive with liver metastasis three years after surgery. Despite being regarded as an extremely aggressive procedure, ELRA could be considered in the treatment of advanced leiomyosarcoma with Budd-Chiari syndrome and hepatic vein thrombi.
No takes yet. Share an insight, caveat, or question.
Tuxun et al. (2021) conducted a case report in Zone II-III Leiomyosarcoma of the Inferior Vena Cava (n=1). Ex vivo liver resection and autotransplantation (ELRA) was evaluated on Survival and recurrence. Ex vivo liver resection and autotransplantation allowed for the successful treatment of an advanced zone II-III leiomyosarcoma of the inferior vena cava, with the patient surviving 32 months post-surgery despite hepatic recurrence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: